Manufacturing

Jul 29, 2015
By BioPharm International Editors
The contract is a memorandum of understanding for the manufacturing by MaSTherCell of clinical batches of TxCell’s Ovasave.
Jul 21, 2015
By BioPharm International Editors
Biogen will take ownership of Eisai's Research Triangle Park manufacturing campus and will manufacture both oral solid-dose and parenteral drugs for Eisai.
Jul 21, 2015
By BioPharm International Editors
The $19.7 million contract will assist Emergent with the development of cGMP lots of three Ebola mAbs.
Jul 20, 2015
By BioPharm International Editors
Baxter has initiated a voluntary recall of two lots of IV solutions due to the potential presence of particulate matter.
Jul 16, 2015
By BioPharm International Editors
Sanofi's new business-unit structure focuses on growth drivers.
Jul 15, 2015
By BioPharm International Editors
The Mobius 2000-L single-use bioreactor from EMD Millipore offers configurable software, hardware, and single-use Flexware assemblies for suspension and adherent cell-culture applications.
Jul 14, 2015
By BioPharm International Editors
FDA released news of the ban of Emcure’s Hinjewadi manufacturing plant after it determined the plant did not meet basic quality standards.
Jul 07, 2015
By BioPharm International Editors
The European Pharmacopoeia has incorporated new provisions to encourage the use of in-process quality control methods.
Jul 07, 2015
By BioPharm International Editors
Catalent licenses Excelimmune’s antibody combination therapy platform to enable the manufacture of multiple recombinant antibodies in a single batch culture.
Jul 06, 2015
By BioPharm International Editors
Biogen plans to build a biologics manufacturing plant in northwest Switzerland using next-generation technologies to create efficiency and sustainability.
native1_300x100
lorem ipsum